Anti-M Alloimmunization: Management and Outcome at a Single Institution
Abstract Objective The objective of this study was to review the management strategies and outcomes in gravidas with anti-M alloimmunization over 15 years. Study Design Data collected from 195 pregnant patients with anti-M antibodies from July 2000 through June 2016 were reviewed retrospectively. We...
Saved in:
Main Authors: | Bethany Stetson (Author), Scott Scrape (Author), Kara Beth Markham (Author) |
---|---|
Format: | Book |
Published: |
Thieme Medical Publishers, Inc.,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy
by: Yohei Maki, et al.
Published: (2020) -
Intraperitoneal and intracardiac transfusion of recurrent fetal erythroblastosis due to anti-M alloimmunization with unfavorable outcome
by: Tzu-Hung Lin, et al.
Published: (2012) -
Severe fetal hemolytic disease due to anti-M alloimmunization: A case report and literature review
by: Fatemeh Golshahi, et al.
Published: (2024) -
Double-Filtration Plasmapheresis and High-Dose Intravenous Immunoglobulin Therapy in a Case of Anti-M Alloimmunization
by: Shun Yasuda, et al.
Published: (2024) -
Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions
by: Lin Li, et al.
Published: (2017)